Hippo Holdings (HIPO) executive granted time- and performance-based RSU awards

Rhea-AI Filing Summary

Hippo Holdings Inc. executive Torben Ostergaard reported acquiring two grants of common stock on March 2, 2026, through restricted stock unit (RSU) awards covering 14,810 and 9,874 shares at no cash cost. One RSU grant vests in 12 equal quarterly installments starting February 15, 2026 over three years.

The other RSU grant is performance-based, with 50% tied to relative total shareholder return over a three-year period, 25% tied to gross written premium over one year, and 25% tied to adjusted return on equity over one year plus an additional one-year service requirement. Following these awards, his direct holdings include 67,111 RSUs within his reported share balance.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Ostergaard Torben

Role CEO Spinnaker

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,810	$0.00	--
Grant/Award	Common Stock	9,874	$0.00	--

Holdings After Transaction: Common Stock — 60,904 shares (Direct)

Footnotes (1)

1. 1/12th of the RSU shares shall vest on each quarterly anniversary of February 15, 2026 over 3 years. The reported RSUs represent performance-based awards granted March 2, 2026, subject to service and performance conditions. The award consists of (i) 50% based on relative total shareholder return over a three-year performance period (vesting after three years), (ii) 25% based on gross written premium measured over a one-year performance period (vesting upon achievement), and (iii) 25% based on adjusted return on equity measured over a one-year performance period, subject to an additional one-year service requirement prior to vesting. Includes 67,111 RSUs.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ostergaard Torben

(Last) (First) (Middle)

C/O HIPPO HOLDINGS INC., 1 ALMADEN BLVD

SUITE 400

(Street)

SAN JOSE CA 95113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hippo Holdings Inc. [ HIPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO Spinnaker

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		14,810(1)	A	$0.00	60,904	D
Common Stock	03/02/2026		A		9,874(2)	A	$0.00	70,778(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 1/12th of the RSU shares shall vest on each quarterly anniversary of February 15, 2026 over 3 years.

2. The reported RSUs represent performance-based awards granted March 2, 2026, subject to service and performance conditions. The award consists of (i) 50% based on relative total shareholder return over a three-year performance period (vesting after three years), (ii) 25% based on gross written premium measured over a one-year performance period (vesting upon achievement), and (iii) 25% based on adjusted return on equity measured over a one-year performance period, subject to an additional one-year service requirement prior to vesting.

3. Includes 67,111 RSUs.

Remarks:

	/s /Guy Zeltser, Attorney-in-Fact for Torben Ostergaard	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hippo Holdings (HIPO) report for Torben Ostergaard?

Hippo Holdings reported that executive Torben Ostergaard acquired two restricted stock unit grants on March 2, 2026, covering 14,810 and 9,874 shares of common stock. These awards were granted at no cash cost as part of his equity compensation.

How do Torben Ostergaard’s time-based RSUs at Hippo Holdings (HIPO) vest?

One RSU grant to Torben Ostergaard vests over three years, with 1/12 of the shares vesting on each quarterly anniversary of February 15, 2026. This schedule spreads the vesting evenly across 12 quarters, aligning continued service with share delivery.

What performance metrics affect Torben Ostergaard’s RSUs at Hippo Holdings (HIPO)?

The performance-based RSUs use three metrics: 50% depends on relative total shareholder return over three years, 25% on gross written premium over one year, and 25% on adjusted return on equity over one year, plus an extra one-year service period before final vesting.

When were Torben Ostergaard’s performance-based RSUs at Hippo Holdings (HIPO) granted?

The performance-based RSUs for Torben Ostergaard were granted on March 2, 2026. They are subject to both service and performance conditions, with different vesting timelines tied to shareholder return, gross written premium, and adjusted return on equity goals.

How many RSUs are currently included in Torben Ostergaard’s Hippo Holdings (HIPO) holdings?

Torben Ostergaard’s reported holdings include 67,111 restricted stock units. These RSUs form part of his overall equity position in Hippo Holdings, alongside other directly held common stock reported after the March 2, 2026 awards.

Are Torben Ostergaard’s recent Hippo Holdings (HIPO) awards open-market purchases?

No, the transactions are not open-market purchases. They are equity compensation grants reported with code A, reflecting awards of restricted stock units at a stated price of $0.00 per share rather than cash-funded stock purchases.